185 related articles for article (PubMed ID: 10767456)
1. Intravesical treatment of overactive bladder.
Fowler CJ
Urology; 2000 May; 55(5A Suppl):60-4; discussion 66. PubMed ID: 10767456
[TBL] [Abstract][Full Text] [Related]
2. [Intravesical treatment of overactive bladder syndrome].
Haferkamp A; Hohenfellner M
Urologe A; 2006 Oct; 45(10):1283-8. PubMed ID: 16972089
[TBL] [Abstract][Full Text] [Related]
3. Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
Lose G; Nørgaard JP
BJU Int; 2001 Jun; 87(9):767-73. PubMed ID: 11412211
[No Abstract] [Full Text] [Related]
4. Intravesical therapy for overactive bladder.
Evans RJ
Curr Urol Rep; 2005 Nov; 6(6):429-33. PubMed ID: 16238916
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders.
Cruz F
Int Urogynecol J Pelvic Floor Dysfunct; 1998; 9(4):214-20. PubMed ID: 9795827
[TBL] [Abstract][Full Text] [Related]
6. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder.
Chancellor MB; de Groat WC
J Urol; 1999 Jul; 162(1):3-11. PubMed ID: 10379728
[TBL] [Abstract][Full Text] [Related]
7. Intravesical vanilloids and neurogenic incontinence: ten years experience.
Lazzeri M; Spinelli M; Zanollo A; Turini D
Urol Int; 2004; 72(2):145-9. PubMed ID: 14963356
[TBL] [Abstract][Full Text] [Related]
8. Intravesical neuromodulatory drugs: capsaicin and resiniferatoxin to treat the overactive bladder.
Kim DY; Chancellor MB
J Endourol; 2000 Feb; 14(1):97-103. PubMed ID: 10735579
[TBL] [Abstract][Full Text] [Related]
9. Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases.
Lazzeri M; Spinelli M; Beneforti P; Zanollo A; Turini D
Scand J Urol Nephrol; 1998 Sep; 32(5):331-4. PubMed ID: 9825395
[TBL] [Abstract][Full Text] [Related]
10. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial.
Kim JH; Rivas DA; Shenot PJ; Green B; Kennelly M; Erickson JR; O'Leary M; Yoshimura N; Chancellor MB
J Spinal Cord Med; 2003; 26(4):358-63. PubMed ID: 14992337
[TBL] [Abstract][Full Text] [Related]
11. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study.
Giannantoni A; Di Stasi SM; Stephen RL; Navarra P; Scivoletto G; Mearini E; Porena M
J Urol; 2002 Apr; 167(4):1710-4. PubMed ID: 11912393
[TBL] [Abstract][Full Text] [Related]
12. Effects of resiniferatoxin desensitization of capsaicin-sensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats.
Zhang X; Igawa Y; Ishizuka O; Nishizawa O; Andersson KE
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):473-9. PubMed ID: 12700886
[TBL] [Abstract][Full Text] [Related]
13. [Intravesical oxybutynin hydrochloride in the treatment of urge incontinence in the elderly].
Mizunaga M; Miyata M; Kaneko S; Taniguchi N; Yachiku S; Chiba K; Osanai H; Fujisawa M
Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):923-7. PubMed ID: 8753011
[TBL] [Abstract][Full Text] [Related]
14. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.
Fader M; Glickman S; Haggar V; Barton R; Brooks R; Malone-Lee J
J Urol; 2007 Jan; 177(1):208-13; discussion 213. PubMed ID: 17162046
[TBL] [Abstract][Full Text] [Related]
15. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.
de Sèze M; Wiart L; de Sèze MP; Soyeur L; Dosque JP; Blajezewski S; Moore N; Brochet B; Mazaux JM; Barat M; Joseph PA
J Urol; 2004 Jan; 171(1):251-5. PubMed ID: 14665887
[TBL] [Abstract][Full Text] [Related]
16. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
Amark P; Bussman G; Eksborg S
Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
[TBL] [Abstract][Full Text] [Related]
17. Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens.
Di Stasi SM; Giannantoni A; Vespasiani G; Navarra P; Capelli G; Massoud R; Stephen RL
J Urol; 2001 Feb; 165(2):491-8. PubMed ID: 11176403
[TBL] [Abstract][Full Text] [Related]
18. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia.
Silva C; Rio ME; Cruz F
Eur Urol; 2000 Oct; 38(4):444-52. PubMed ID: 11025384
[TBL] [Abstract][Full Text] [Related]
19. Intravesical capsaicin for treatment of detrusor hyperreflexia.
Fowler CJ; Beck RO; Gerrard S; Betts CD; Fowler CG
J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):169-73. PubMed ID: 8126498
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravesical instillation of ATP on rat bladder primary afferent activity and its relationship with capsaicin-sensitivity.
Aizawa N; Igawa Y; Andersson KE; Iijima K; Nishizawa O; Wyndaele JJ
Neurourol Urodyn; 2011 Jan; 30(1):163-8. PubMed ID: 20665548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
